The Director, Biologics Development leads the strategy and execution of biologics development activities to advance Dyne’s therapeutic programs from early-stage development through clinical and commercial readiness. This role shapes development strategies, ensures alignment across cross-functional teams, and drives technical excellence in biologics development. The Director applies deep scientific and industry expertise to solve complex challenges, influence decision-making, and enable successful program delivery that supports Dyne’s mission of delivering meaningful outcomes for patients. The role will ensure the delivery of robust, scalable, and cost-effective second-generation manufacturing processes, serve as the primary technical lead for external CDMOs, driving aggressive timelines while delivering well-characterized products optimized for our proprietary bioconjugation platform. As a core CMC team member, the Director of Biologics Development will steer the development of preclinical assets and define CMC strategies within a matrixed environment. The role will play a critical role in global regulatory filings (IND, IMPD, etc.) by authoring and reviewing key Module 3 sections. This role is based in Waltham, MA and requires regular onsite presence, typically four to five days per week.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director